Patients with systemic lupus erythematosus and diabetes who received sodium-glucose cotransporter 2 inhibitors exhibited ...

DTx-based cardio-oncology rehabilitation for lung cancer survivors: A randomized controlled trial. a After propensity score matching by incorporating variables: age, sex, metastatic disease, androgen ...

Empagliflozin is a potential treatment for outpatients with chronic hyponatremia due to the syndrome of inappropriate antidiuresis (SIAD), new data suggest. The sodium-glucose cotransporter 2 (SGLT2) ...

About The Study: In this study of discharge prescription of a sodium-glucose cotransporter-2 inhibitor (SGLT2i) among patients hospitalized for heart failure, prescription rates increased ...

Prophylactic use of metformin in patients on alpelisib treatment. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full text component.

A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)—or ...

In the absence of head-to-head randomized trials, investigators performed a network meta-analysis to compared drugs for post-transplant diabetes.

Medically reviewed by Alex Yampolsky, PharmD Key Takeaways ACE inhibitors lower blood pressure and protect the kidneys by ...